Figure 6

The expression of downstream proteins (cdk 2 signaling pathway).
(a) The decrease in the expression of podocan was associated with an increase in cdk2 expression (p = 0.002) (b) and a decrease in p21 expression (p = 0.0095). (c) The increase in expression of podocan was associated with a decrease in cdk2 expression (p = 0.0002) (d) and increase in p21 expression (p = 0.011).